HR 2433
114th Congress
House
To amend the Federal Food, Drug, and Cosmetic Act with respect to enhancing combination products review.
Health
Administrative law and regulatory proceduresDepartment of Health and Human ServicesDrug safety, medical device, and laboratory regulationFood and Drug Administration (FDA)
Everywhere this bill has been
3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
May 22, 2015
Referred to the Subcommittee on Health.
May 19, 2015
Referred to the House Committee on Energy and Commerce.
May 19, 2015
Introduced in House
Ask about this bill
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Latest action
Referred to the Subcommittee on Health.
Plain-English summary
This bill amends the Federal Food, Drug, and Cosmetic Act to require the Food and Drug Administration to describe the responsibilities of each agency center charged with reviewing drugs, medical devices, or biological products when reviewing a product that is a combination of drug, medical device, or biological product.
Related & companion bills
1
Bill text
1 version
- Introduced in House Formatted Text PDF Formatted XML
Committees of jurisdiction
2
Cite this page
U.S. Congress. (2026). H.R. 2433: To amend the Federal Food, Drug, and Cosmetic Act with respect to enhancing combination products review.. 114th Congress. Open America. https://openamerica.io/bill/114-HR-2433/
"H.R. 2433: To amend the Federal Food, Drug, and Cosmetic Act with respect to enhancing combination products review.." 114th Congress, 2026, Open America, https://openamerica.io/bill/114-HR-2433/.
H.R. 2433, 114th Cong. (2026), https://openamerica.io/bill/114-HR-2433/.
[H.R. 2433: To amend the Federal Food, Drug, and Cosmetic Act with respect to enhancing combination products review.](https://openamerica.io/bill/114-HR-2433/)